Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric germ cell tumors: protocol update for pathologists.

E J Perlman1, E P Hawkins

  • 1Department of Pathology, Johns Hopkins Hospital, Baltimore, MD 21287, USA.

Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
|August 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data set for reporting paediatric renal tumours: recommendations from the international collaboration on cancer reporting (ICCR).

Histopathology·2025
Same author

International cancer seminars: a focus on kidney cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

CD84 is markedly up-regulated in Kawasaki disease arteriopathy.

Clinical and experimental immunology·2014
Same author

Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.

The Journal of pathology·2008
Same author

Molecular cytogenetic characterization of pancreas cancer cell lines reveals high complexity chromosomal alterations.

Cytogenetic and genome research·2007
Same author

Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour.

The Journal of pathology·2006

Pediatric germ cell tumor treatment is becoming more standardized through Intergroup protocols. Early-stage testicular germ cell tumors and immature teratomas can be treated with surgery and observation alone.

Area of Science:

  • Pediatric Oncology
  • Germ Cell Tumors
  • Clinical Trial Design

Background:

  • Historically, pediatric germ cell tumor (GCT) therapy lacked standardization, varying significantly between institutions.
  • Recent Intergroup protocols have introduced a framework for consistent, biology-driven treatment strategies.
  • This shift aims to improve outcomes and facilitate future research in pediatric GCTs.

Purpose of the Study:

  • To review the findings of initial Intergroup protocols for pediatric GCTs.
  • To outline potential future directions for GCT treatment based on current data and emerging challenges.
  • To emphasize the importance of accurate staging and biologic studies in refining GCT management.

Main Methods:

  • Analysis of outcomes from the first Intergroup protocols for pediatric GCTs.

Related Experiment Videos

  • Identification of pathological factors influencing treatment decisions and future protocol design.
  • Discussion of the need for international collaboration and companion biologic studies.

    • Main Results:

    • Confirmed that surgery alone followed by observation is effective for stage I malignant testicular GCTs and immature teratomas.
    • Identified pathological challenges, such as endodermal sinus tumor foci, impacting treatment stratification.
    • Highlighted the critical role of accurate staging and the potential for new risk categories (e.g., intermediate for low-stage extragonadal GCTs).

    Conclusions:

    • Initial Intergroup protocols have successfully established a foundation for standardized pediatric GCT therapy.
    • Future protocols may expand the scope to include ovarian GCTs and refine risk stratification for extragonadal tumors.
    • Advancements in staging accuracy, international cooperation, and biologic studies are essential for personalized GCT treatment.